Cargando…
Mesenchymal Stem Cells Pretreated with HGF and FGF4 Can Reduce Liver Fibrosis in Mice
Stem cells have opened a new avenue to treat liver fibrosis. We investigated in vitro and in vivo the effect of cytokine (HGF and FGF4) pretreated MSCs in reduction of CCl(4) liver injury. Mouse MSCs were pretreated with cytokines to improve their ability to reduce CCl(4) injury. In vitro we gave CC...
Autores principales: | Shams, Sulaiman, Mohsin, Sadia, Nasir, Ghazanfar Ali, Khan, Mohsin, Khan, Shaheen N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320872/ https://www.ncbi.nlm.nih.gov/pubmed/25685159 http://dx.doi.org/10.1155/2015/747245 |
Ejemplares similares
-
Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice
por: Nasir, Ghazanfar Ali, et al.
Publicado: (2013) -
Nitric oxide augments mesenchymal stem cell ability to repair liver fibrosis
por: Ali, Gibran, et al.
Publicado: (2012) -
Repair of senescent myocardium by mesenchymal stem cells is dependent on the age of donor mice
por: Khan, Mohsin, et al.
Publicado: (2011) -
Mesenchymal stem cells conditioned with glucose depletion augments their ability to repair-infarcted myocardium
por: Choudhery, Mahmood S, et al.
Publicado: (2012) -
Preconditioning diabetic mesenchymal stem cells with myogenic medium increases their ability to repair diabetic heart
por: Khan, Mohsin, et al.
Publicado: (2013)